Yahoo
NYSE - Delayed Quote USD

The Cigna Group (CI)

279.27 -5.82 (-2.04%)
At close: June 18 at 4:00:03 PM EDT
282.00 +2.73 (+0.98%)
After hours: June 18 at 7:40:11 PM EDT
Trade CI on Coinbase
Chart Range Bar
Loading chart for CI

News headlines Cigna (CI) faces a challenging landscape with shrinking customer numbers despite strong revenue growth and improved regulatory stability. Analysts have raised price targets, reflecting a cautiously optimistic outlook amidst ongoing cost pressures.

Cigna (CI) faces a challenging landscape with shrinking customer numbers despite strong revenue growth and improved regulatory stability. Analysts have raised price targets, reflecting a cautiously optimistic outlook amidst ongoing cost pressures.

Updated 24m ago · Powered by Yahoo Scout
  • Previous Close 285.09
  • Open 284.83
  • Bid 279.90 x 12000
  • Ask 287.19 x 12000
  • Day's Range 279.31 - 286.19
  • 52 Week Range 239.51 - 338.89
  • Volume 2,440,913
  • Avg. Volume 1,590,450
  • Market Cap (intraday) 73.876B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 11.18
  • EPS (TTM) 24.99
  • Earnings Date Jul 30, 2026
  • Forward Dividend & Yield 6.24 (2.23%)
  • Ex-Dividend Date Jun 4, 2026
  • 1y Target Est 340.50

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

www.thecignagroup.com

65,669

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview

Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CI
2.62%
S&P 500 (^GSPC)
9.57%

1-Year Return

CI
9.21%
S&P 500 (^GSPC)
25.41%

3-Year Return

CI
9.98%
S&P 500 (^GSPC)
70.10%

5-Year Return

CI
32.00%
S&P 500 (^GSPC)
80.02%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 68.49B
Earnings 2.06B

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
20B
40B
60B

Analyst Insights

View More

Analyst Price Targets

290.00
340.50 Average
279.27 Current
400.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/8/2026
Analyst Mizuho
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 330 -> 340

Statistics

View More

Valuation Measures

Annual
As of 5/29/2026
  • Market Cap

    73.88B

  • Enterprise Value

    96.98B

  • Trailing P/E

    11.17

  • Forward P/E

    9.20

  • PEG Ratio (5yr expected)

    0.84

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    1.75

  • Enterprise Value/Revenue

    0.35

  • Enterprise Value/EBITDA

    7.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.26%

  • Return on Assets (ttm)

    4.78%

  • Return on Equity (ttm)

    16.27%

  • Revenue (ttm)

    277.89B

  • Net Income Avi to Common (ttm)

    6.29B

  • Diluted EPS (ttm)

    24.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.85B

  • Total Debt/Equity (mrq)

    72.80%

  • Levered Free Cash Flow (ttm)

    6.92B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

279.27 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $321.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $321.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $325.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $325.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
  • Lowering target price to $300.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $300.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $309.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $309.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: